ALEXANDRIA, Va., June 16 -- United States Patent no. 12,304,964, issued on May 20, was assigned to BLACK BELT THERAPEUTICS Ltd. (Stevenage, Great Britain).
"CD38 modulating antibody" was invented by Anne Goubier (Stevenage, Great Britain), Josephine Salimu (Stevenage, Great Britain), Kevin Moulder (Stevenage, Great Britain), Beatriz Goyenechea Corzo (Stevenage, Great Britain), Simone Filosto (Stevenage, Great Britain), Pascal Merchiers (Stevenage, Great Britain), Nina Eissler (Stevenage, Great Britain), Hemanta Baruah (Lebanon, N.H.) and Bianka Prinz (Lebanon, N.H.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibody sequences found in antibodies that bind to human CD38. In...